MedTech and SaMD startups
Independent technical review before investor due diligence, clinical pilots, certification preparation, or production deployment.
Independent AI/ML medical model audit
I help MedTech, digital health, pharma, clinical AI, and biomedical research teams evaluate whether their AI/ML models are scientifically valid, reproducible, explainable, bias-aware, and ready for clinical, investor, production, or regulatory-facing decisions.
From SaaS to on-device AI
Many medical AI failures are not architecture failures. They are evidence failures: weak validation design, hidden leakage, confounding, poor calibration, unstable features, subgroup blind spots, irreproducible notebooks, or deployment assumptions that do not match the intended use.
Independent technical review before investor due diligence, clinical pilots, certification preparation, or production deployment.
Independent technical due diligence on medical AI, SaMD, digital health, biomarker, LLM/CDSS, and on-device AI startups before investment decisions.
Review of cloud-based diagnostic, prognostic, triage, clinical decision-support, and monitoring systems.
Assessment of compact, edge, ultrasound, wearable, mobile, and embedded models where compute, data, and deployment constraints matter.
Audit of biomarker discovery, omics pipelines, patient stratification, clinical prediction, and multimodal biomedical AI claims.
For investors and technical due diligence teams
I support angel investors, venture capital funds, family offices, corporate innovation teams, and strategic partners with independent technical due diligence on medical AI, SaMD, digital health, biomarker, clinical decision-support, and on-device AI companies.
The review focuses on whether the startup's AI claims are scientifically credible, reproducible, clinically meaningful, bias-aware, and aligned with the claimed intended use. This may include assessment of validation design, data leakage, external validation, subgroup performance, calibration, explainability, deployment assumptions, regulatory-facing evidence gaps, and whether reported performance is likely to generalize beyond the development dataset.
Structured engagement options
Fast independent review of model validity, leakage risks, metrics, documentation gaps, and next-step priorities.
Deep review of data, code, splits, features, training, validation, XAI, bias/confounding, and reproducibility.
Technical gap analysis of evidence, intended-use alignment, clinical validation, model documentation, and reporting claims.
Review of deployment, monitoring, drift, calibration, model-size constraints, low-resource inference, and operational risks.
Independent assessment of a medical AI company's technical claims, evidence quality, validation maturity, deployment assumptions, and scientific credibility.
Important scope note
I provide independent scientific, statistical, and machine-learning evidence support for regulatory-facing, clinical, investor, and production-readiness decisions. This work does not replace notified bodies, legal counsel, quality-management specialists, or regulatory affairs consultants.
Start with a short scoping message
Send a short description of your model, data modality, intended use, current validation stage, deployment context, and timeline. I will respond with the most appropriate audit format.
Direct contact
For confidential or early-stage projects, send a short non-confidential summary first.